Prostate cancer cases have been increasing in recent years, up 3% per year since 2014 – now, former President Joe Biden is one of 300,000 people diagnosed this year.
Biden's office made the news Sunday, and a few days later it was reported that a "small nodule" was found in the former president's prostate during regular exams.
"While this represents a more aggressive form of the disease, cancer appears to be hormone-sensitive and can be managed effectively," his office said. "The president and his family are reviewing treatment options with doctors."
The new prostate cancer test is better than the PSA option, the study found.
According to Mayo Clinic, treatment is often more effective when state cancer is hormone-sensitive, because it means the disease may respond better to hormone treatment.
Hormone therapy is used to block the effects of hormones, thereby increasing the growth of prostate cancer cells.
Former President Joe Biden is one of 300,000 people diagnosed with prostate cancer this year. (Getty Image)
The above source said: "Prostate cancer cells rely on testosterone to help them grow. Cutting off the supply of testosterone may cause cancer cells to die or grow more slowly."
In addition to hormone therapy, common treatment options for prostate cancer include chemotherapy, targeted therapy, immunotherapy, and radiopharmaceutical therapy.
Prostate cancer It is a disease found in men with prostate development.
According to the American Cancer Society, about 313,780 new cases of prostate cancer will be diagnosed and 35,770 men will die from the disease.
Hormone therapy is used to block the effects of hormones, thereby increasing the growth of prostate cancer cells.
The same source said one in eight men will be diagnosed with prostate cancer in their lifetime.
Older men are at a higher risk of developing the disease, with six out of 10 diagnosed in patients aged 65 and older. The average age at diagnosis is 67 years old, and men under 40 are rarely affected. Biden is 82.
More aggressive disease patients are now available for prostate cancer drugs
Prostate cancer is the second most common cancer among men, second only to Skin cancerACS noted.
In men who are screened for routine prostate cancer, according to ACS, the disease is usually captured before symptoms appear.
Typical early symptoms include urination problems, weak or slow urine flow or increased demand for urination.
According to the American Cancer Society, about 313,780 new cases of prostate cancer will be diagnosed, with 35,770 men dying from the disease in 2025. (iStock)
Some men may also notice blood in urine or body fluids.
More advanced symptoms may occur after the disease spreads. These may include pain in the buttocks, back (spine), chest (ribs), or other areas, as ACS says.
Click here to get the Fox News app
Men may also suffer from erectile dysfunction, weight loss, extreme fatigue, weakness in their legs or feet or loss of bladder control or intestinal control.
The U.S. Preventive Service Task Force notes that men aged 55 to 69 should have the option of periodic prostate-specific antigen (PSA) screening to monitor prostate cancer.
"Before deciding whether to screen, men should have the opportunity to discuss the potential benefits and harms of screening with clinicians and incorporate their values and preferences into the decision," the USPSTF noted.
While screening provides “little potential benefits” to reduce the chances of death from the disease, health officials warn that some men may have negative effects. (iStock)
While screening provides “little potential benefits” to reduce the chances of disease death, the agency notes that some men may experience negative effects, including false positive results, overdiagnosis and overtreatment, and treatment complications.
As Fox News Digital recently reported, alternative prostate cancer screening methods are currently being studied, including methods using non-invasive urine tests.
According to ACS, the five-year survival rate is at least 99% for local prostate cancers with the disease containing the prostate.
Click here to sign up for our health newsletter
For regional cases where the disease only spreads to "nearby structures or lymph nodes", the five-year survival rate is also 99% or higher.
For more health articles, please visit www.foxnews.com/health
If the cancer has spread to other areas of the body, the five-year survival rate drops to 37%.
The ACS notes that actual survival rates may vary based on the patient's age, overall health, cancer progression, disease response to treatment, and other factors.